Biblio

11 resultats trouvés
Filtres: Auteur is Cotte, Francois-Emery  [Clear All Filters]
A
Scherpereel A, Durand-Zaleski I, Cotte F-E, Fernandes J, Debieuvre D, Blein C, Gaudin A-F, Tournier C, Vainchtock A, Chauvin P et al..  2018.  Access to innovative drugs for metastatic lung cancer treatmentin a French nationwide cohort: the TERRITOIRE study. BMC CANCER. 18:1013.
D
Chouaid C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, Blein C, Gaudin A-F, Ozan N, Saitta B et al..  2015.  Disparities in Lung Cancer Incidence and Management Care in France: A Nationwide Cohort Study (the TERRITOIRE Study). JOURNAL OF THORACIC ONCOLOGY. 10:S226-S227.
Chouaid C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, Blein C, Gaudin A-F, Ozan N, Saitta B et al..  2015.  Disparities in Lung Cancer Incidence and Management Care in France: A Nationwide Cohort Study (the TERRITOIRE Study). JOURNAL OF THORACIC ONCOLOGY. 10:S226-S227.
E
Barlesi F, Dixmier A, Debieuvre D, Raspaud C, Auliac J-B, Benoit N, Bombaron P, Moro-Sibilot D, Audigier-Valette C, Asselain B et al..  2020.  Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study. ONCOIMMUNOLOGY. 9:1744898.
I
Anota A, Pozet A, Lemasson H, Cotte F-E, Guerzider S, Mouillet G, Eberst G, Charton E, Westeel V.  2020.  Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: a 10-year systematic literature review (SLR). QUALITY OF LIFE RESEARCH. 29:S156.
Anota A, Pozet A, Lemasson H, Cotte F-E, Guerzider S, Mouillet G, Eberst G, Charton E, Westeel V.  2020.  Impact of open-label design on patient-reported outcomes (PROs) data in randomized clinical trials of immuno-oncology (IO) agents in patients with advanced or metastatic cancer: a 10-year systematic literature review (SLR). QUALITY OF LIFE RESEARCH. 29:S156.
Westeel V, Bourdon M, Cortot A, Debieuvre D, Toffart A-claire, Acquadro M, Arnould B, Lambert J, Cotte F-E, Gaudin A-F et al..  2020.  Integrating patients' quality of life (QoL) into clinical practice: a Delphi method-based consensus among French physicians managing lung cancer patients. QUALITY OF LIFE RESEARCH. 29:S110.
Westeel V, Bourdon M, Cortot A, Debieuvre D, Toffart A-claire, Acquadro M, Arnould B, Lambert J, Cotte F-E, Gaudin A-F et al..  2020.  Integrating patients' quality of life (QoL) into clinical practice: a Delphi method-based consensus among French physicians managing lung cancer patients. QUALITY OF LIFE RESEARCH. 29:S110.
S
Souquet PJean, Durand-Zaleski I, Chouaid C, Debieuvre D, Scherpereel A, Fernandes J, Westeel V, Blein C, Gaudin A-F, Leblanc S et al..  2017.  Socioeconomic Determinants of Late Diagnosis of Lung Cancer in France: A Nationwide Study (the TERRITOIRE Study). JOURNAL OF THORACIC ONCOLOGY. 12:S306.
Souquet PJean, Durand-Zaleski I, Chouaid C, Debieuvre D, Scherpereel A, Fernandes J, Westeel V, Blein C, Gaudin A-F, Leblanc S et al..  2017.  Socioeconomic Determinants of Late Diagnosis of Lung Cancer in France: A Nationwide Study (the TERRITOIRE Study). JOURNAL OF THORACIC ONCOLOGY. 12:S306.
Chouaid C, Debieuvre D, Durand-Zaleski I, Fernandes J, Scherpereel A, Westeel V, Blein C, Gaudin A-F, Ozan N, Leblanc S et al..  2017.  Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study). PLOS ONE. 12:e0182798.